transform acquisit
bristol-my announc plan acquisit celgen
bristol chairman ceo giovanni caforio
lead new compani manag expect deal close
complementari franchis pipelin indic slide
transact creat oncolog franchis combin bristol-my
leader solid tumour celgen cover matthew harrison leader
blood tumor product portfolio fit well includ lead franchis
oncolog immunology/inflamm cardiovascular diseas combin
compani expect launch six new drug manag highlight
well-align pipelin oncolog immunolog inflamm head
tom lynch state combin compani candid
develop offer substanti new product potenti time
strong financi prospect bristol anticip non-gaap ep accret
first full year follow deal close free cash flow gener
first three full year post-clos expect run-rat cost
synergi separ bristol guid stand-alon non-gaap ep
consensu despit dilut associ upsa divestitur
us pension liabil transact guid ep
midpoint con
manag discuss revlimid patent concern highlight next event
watch revlimid celgen largest asset management address intellectu
properti timelin slide investor present chairman ceo
caforio state bristol took conserv view revlimid sale
prospect assumpt consensu project newsflow watch
februari ptab decis ipr file dr reddi cover sameer
baisiwala method use patent myelodysplast syndrom md
repres low singl digit percentag current revlimid sale institut
ptab patent decis would occur month later feb
unexpect event revlimid patent invalid investor would debat
whether dr reddi could launch non-infring polymorph gener
carv label drive gener revlimid adopt beyond md separ
regard court trial proceed gener challeng management expect
earliest initi trial decis late earli potenti appel
major pharmaceut unit state america
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
court decis
happen bristol-my announc acquisit celgen
per celgen share one cvr cvr entitl holder
receiv one-tim potenti payment cash upon fda approv
three ozanimod dec liso-cel dec
case specifi indic
act financi advisor bristol-my squibb compani
bristol-my relat propos acquisit celgen corpor
celgen announc januari propos transact subject
customari close condit includ bristol-my celgen stockhold
approv receipt customari close condit regulatori approv
report inform provid herein intend provid vote
advic ii serv endors propos transact iii result
procur withhold revoc proxi action secur
holder bristol-my agre pay fee financi
servic includ transact fee financ fee conting upon
consumm transact pleas refer note end report
act financi advisor bristol-my squibb compani
bristol-my connect termin pension
oblig oblig distribut combin lump sum
plan particip elect payment purchas group annuiti
contract athen annuiti life compani wholly-own insur
subsidiari athen hold ltd announc decemb annuiti
transact subject customari close condit bristol-my agre
pay fee financi advic includ transact fee
conting upon consumm propos transact pleas refer
note end report
inform opinion research prepar co llc and/or and/or morgan
stanley mexico de bolsa de and/or canada limit use disclosur section includ morgan
stanley co llc mexico de bolsa de canada limit affili
necessari
import disclosur stock price chart equiti rate histori regard compani subject report pleas see morgan
stanley research disclosur websit www morganstanley com/researchdisclosur contact invest repres
research broadway attent research manag new york ny usa
valuat methodolog risk associ recommend rate price target referenc research report pleas contact client
support follow us/canada hong kong latin america london
singapor sydney tokyo altern may contact invest repres morgan
stanley research broadway attent research manag new york ny usa
follow analyst herebi certifi view compani secur discuss report accur express
receiv receiv direct indirect compens exchang express specif recommend view report matthew
unless otherwis state individu list cover page report research analyst
morgan stanley research publish accord conflict manag polici avail
www morganstanley com/institutional/research/conflictpolici portugues version polici found www morganstanley com br
import us regulatori disclosur subject compani
novemb benefici own class common equiti secur follow compani cover
within last month manag co-manag public offer offer secur abbvi inc co pfizer inc
within last month receiv compens invest bank servic abbvi inc bristol-my squibb co
next month expect receiv intend seek compens invest bank servic abbvi inc bristol-my
within last month receiv compens product servic invest bank servic abbvi inc
within last month provid provid invest bank servic invest bank client relationship
follow compani abbvi inc bristol-my squibb co celgen corp co merck co inc pfizer inc
within last month either provid provid non-invest bank securities-rel servic and/or past
enter agreement provid servic client relationship follow compani abbvi inc bristol-my squibb co celgen corp
employe director consult director merck co inc person research analyst member research
 co llc make market secur abbvi inc bristol-my squibb co celgen corp co merck co inc
equiti research analyst strategist princip respons prepar research receiv compens base upon
variou factor includ qualiti research investor client feedback stock pick competit factor firm revenu overal invest bank
revenu equiti research analyst strategist compens link invest bank capit market transact perform morgan
stanley profit revenu particular trade desk
affili busi relat companies/instru cover research includ market make provid
liquid fund manag commerci bank extens credit invest servic invest bank sell buy
custom securities/instru compani cover research princip basi may posit debt
compani instrument discuss report trade may trade princip debt secur relat deriv
subject debt research report
certain disclosur list also complianc applic regul non-u jurisdict
use rel rate system use term overweight equal-weight not-rat underweight see definit morgan
stanley assign rate buy hold sell stock cover overweight equal-weight not-rat underweight equival
buy hold sell investor care read definit rate use morgan stanley research addit sinc morgan stanley research
contain complet inform concern analyst view investor care read morgan stanley research entireti infer
content rate alon case rate research use reli upon invest advic investor decis buy sell
stock depend individu circumst investor exist hold consider
decemb
stock rate describ appli fundament equiti research appli debt research produc firm
disclosur purpos accord nasd nyse requir includ categori head buy hold sell alongsid
rate overweight equal-weight not-rat underweight assign rate buy hold sell stock cover
overweight equal-weight not-rat underweight equival buy hold sell repres recommend rel weight see
definit satisfi regulatori requir correspond overweight posit stock rate buy recommend correspond
equal-weight not-rat hold underweight sell recommend respect
data includ common stock adr current assign rate invest bank client compani receiv invest
bank compens last month due round decim percentag provid total column may add exactli
overweight stock total return expect exceed averag total return analyst industri industri team coverag univers
risk-adjust basi next month
equal-weight stock total return expect line averag total return analyst industri industri team coverag univers
risk-adjust basi next month
not-rat nr current analyst adequ convict stock total return rel averag total return analyst
industri industri team coverag univers risk-adjust basi next month
underweight stock total return expect averag total return analyst industri industri team coverag univers
risk-adjust basi next month
unless otherwis specifi time frame price target includ morgan stanley research month
attract analyst expect perform industri coverag univers next month attract vs relev broad
market benchmark indic
in-lin analyst expect perform industri coverag univers next month line relev broad market
benchmark indic
cautiou analyst view perform industri coverag univers next month caution vs relev broad market
benchmark indic
benchmark region follow north america latin america relev countri index latin america index europ
europ japan topix asia relev countri index sub-region index ac asia pacif ex japan index
stock price price target rate histori rate definit
import disclosur morgan stanley smith barney llc custom
